Cryoport, Inc. provides temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. The Company supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The Company's segments include Life Sciences Services and Life Sciences Products. The Company's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.
äŒæ¥ã³ãŒãCYRX
äŒç€ŸåCryoport Inc
äžå Žæ¥Jul 24, 2015
æé«çµå¶è²¬ä»»è
ãCEOãShelton (Jerrell Wilson)
åŸæ¥å¡æ°1090
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Jul 24
æ¬ç€Ÿæåšå°112 Westwood Place, Suite 350
éœåžBRENTWOOD
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·37027
é»è©±çªå·19492321900
ãŠã§ããµã€ãhttps://www.cryoport.com/
äŒæ¥ã³ãŒãCYRX
äžå Žæ¥Jul 24, 2015
æé«çµå¶è²¬ä»»è
ãCEOãShelton (Jerrell Wilson)